These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36572262)

  • 1. Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy.
    Anter HM; Aman RM; Othman DIA; Elamin KM; Hashim IIA; Meshali MM
    Int J Pharm; 2023 Jan; 631():122536. PubMed ID: 36572262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma.
    Huang M; Liu J; Fan Y; Sun J; Cheng JX; Zhang XF; Zhai BT; Guo DY
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127219. PubMed ID: 37802456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propitious maneuvering for delivery of the phytopharmaceutical "apocynin" to induced fulminant hepatitis in BALB/c mice: In vitro and in vivo assessments.
    Mohamed Anter H; Mokhtar Aman R; Abdelaziz Shaaban A; Ibrahim Abu Hashim I; Mohamed Meshali M
    Int J Pharm; 2022 Oct; 626():122165. PubMed ID: 36089210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
    Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
    Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
    Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
    Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
    Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma.
    Ganguly S; Dewanjee S; Sen R; Chattopadhyay D; Ganguly S; Gaonkar R; Debnath MC
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111778. PubMed ID: 33915380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.
    Margarida Cardoso M; Peça IN; Raposo CD; Petrova KT; Teresa Barros M; Gardner R; Bicho A
    J Microencapsul; 2016 Jun; 33(4):315-22. PubMed ID: 27189857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
    Pranatharthiharan S; Patel MD; Malshe VC; Pujari V; Gorakshakar A; Madkaikar M; Ghosh K; Devarajan PV
    Drug Deliv; 2017 Nov; 24(1):20-29. PubMed ID: 28155331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.
    Sanna V; Roggio AM; Siliani S; Piccinini M; Marceddu S; Mariani A; Sechi M
    Int J Nanomedicine; 2012; 7():5501-16. PubMed ID: 23093904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
    Huang C; Li NM; Gao P; Yang S; Ning Q; Huang W; Li ZP; Ye PJ; Xiang L; He DX; Tan XW; Yu CY
    Drug Deliv; 2017 Nov; 24(1):459-466. PubMed ID: 28219253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical "apocynin".
    Anter HM; Abu Hashim II; Awadin W; Meshali MM
    Int J Nanomedicine; 2019; 14():4911-4929. PubMed ID: 31456637
    [No Abstract]   [Full Text] [Related]  

  • 18. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
    Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
    Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.